Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Treatment, Safety and Efficacy, Long-term Study of Deferiprone in Subjects With Friedreich's Ataxia

NCT00897221 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT00897221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Treatment, Safety and Efficacy, Long-term Study of Deferiprone in Subjects With Friedreich's Ataxia
Lead sponsor
ApoPharma
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2011
Enrollment
36 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich's ataxia